NO912099D0 - EXPRESSION OF HIV PROTEINS IN DROSOPHILIA CELLS. - Google Patents

EXPRESSION OF HIV PROTEINS IN DROSOPHILIA CELLS.

Info

Publication number
NO912099D0
NO912099D0 NO912099A NO912099A NO912099D0 NO 912099 D0 NO912099 D0 NO 912099D0 NO 912099 A NO912099 A NO 912099A NO 912099 A NO912099 A NO 912099A NO 912099 D0 NO912099 D0 NO 912099D0
Authority
NO
Norway
Prior art keywords
drosophilia
expression
cells
hiv proteins
hiv
Prior art date
Application number
NO912099A
Other languages
Norwegian (no)
Other versions
NO314090B1 (en
NO912099L (en
Inventor
Hanne Ranch Johansen
Martin Rosenberg
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO912099D0 publication Critical patent/NO912099D0/en
Publication of NO912099L publication Critical patent/NO912099L/en
Publication of NO314090B1 publication Critical patent/NO314090B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19912099A 1988-12-01 1991-05-31 HIV protein gene expression unit, DNA vector comprising it, Drosophila cell transfected with the vector, HIV gp 120 and HIV gp 160 protein produced in a culture of said cells, vaccine and diagnostic agent comprising the protein, NO314090B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27838688A 1988-12-01 1988-12-01
PCT/US1989/005155 WO1990006358A1 (en) 1988-12-01 1989-11-29 Expression of hiv proteins in drosophila cells

Publications (3)

Publication Number Publication Date
NO912099D0 true NO912099D0 (en) 1991-05-31
NO912099L NO912099L (en) 1991-07-31
NO314090B1 NO314090B1 (en) 2003-01-27

Family

ID=23064787

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19912099A NO314090B1 (en) 1988-12-01 1991-05-31 HIV protein gene expression unit, DNA vector comprising it, Drosophila cell transfected with the vector, HIV gp 120 and HIV gp 160 protein produced in a culture of said cells, vaccine and diagnostic agent comprising the protein,

Country Status (12)

Country Link
EP (1) EP0446272A4 (en)
JP (1) JP3085704B2 (en)
KR (1) KR0152525B1 (en)
AU (1) AU630649B2 (en)
CA (1) CA2003794C (en)
DK (1) DK175461B1 (en)
FI (1) FI113475B (en)
IL (1) IL92470A (en)
NO (1) NO314090B1 (en)
PT (1) PT92477A (en)
WO (1) WO1990006358A1 (en)
ZA (1) ZA899150B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10040826B2 (en) 2011-07-05 2018-08-07 Duke University Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens
EP2763699A4 (en) 2011-10-03 2015-05-20 Univ Duke Vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258575A (en) * 1986-12-15 1988-10-26 レプリゲン　コーポレーション Recombinant hiv envelope protein produced in insect cell
CA1341345C (en) * 1987-05-08 2002-03-05 Hanne Ranch Johansen Expression of foreign genes in drosophila cells
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
AU634512B2 (en) * 1988-12-21 1993-02-25 Smithkline Biologicals Expression of the plasmodium circumsporozoite protein in insect cells

Also Published As

Publication number Publication date
FI113475B (en) 2004-04-30
CA2003794C (en) 2000-02-08
ZA899150B (en) 1991-04-24
IL92470A0 (en) 1990-08-31
FI912635A0 (en) 1991-05-31
KR0152525B1 (en) 1998-10-01
JPH04501954A (en) 1992-04-09
PT92477A (en) 1990-06-29
IL92470A (en) 1997-01-10
JP3085704B2 (en) 2000-09-11
NO314090B1 (en) 2003-01-27
EP0446272A1 (en) 1991-09-18
KR910700344A (en) 1991-03-14
AU630649B2 (en) 1992-11-05
WO1990006358A1 (en) 1990-06-14
DK104991A (en) 1991-05-31
AU4755290A (en) 1990-06-26
NO912099L (en) 1991-07-31
DK175461B1 (en) 2004-11-01
DK104991D0 (en) 1991-05-31
CA2003794A1 (en) 1990-06-01
EP0446272A4 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
DE68919449T2 (en) Production of IBDV in continuous cell lines.
DE68920223T2 (en) Enzyme electrodes and their manufacture.
DE3687915D1 (en) CHANGE OF FACIAL EXPRESSIONS IN KINEMATOGRAPHY.
DE3750755T2 (en) Anti-sense regulation of gene expression in plant cells.
DE3787356D1 (en) EXPRESSION OF HIGHER EUKARYOTIC GENES IN ASPERGILLUS.
DE68924285T2 (en) Creation of directional holes in silicon.
DE68914571D1 (en) Electrical insertion of proteins in membranes of animal cells.
DE68920414D1 (en) Manufacturing process of solar cells.
NO891718L (en) EXPRESSION OF HUMANT INTERLEUKIN-2 IN METYLOTROPHIC YEARS.
DE3886371D1 (en) MANUFACTURE OF HBLV VIRUS IN THE HSB-2 CELL LINE.
DE3676604D1 (en) EXPRESSION OF EPA IN MAMMAL CELLS.
FI880636A0 (en) FOERFARANDE FOER INAKTIVERING AV MED HOELJE FOERSEDDA VIRUS I EN MEDELST EN CELL IN VITRO FRAMSTAELLDA PROTEINPRODUKTER.
NO912099L (en) EXPRESSION OF HIV PROTEINS IN DROSOPHILIA CELLS.
DE3872886D1 (en) TRANSFER OF SPEED AND SPEED VALUES.
NO891687D0 (en) EXPRESSION OF HEPATITE-B PRES2 PROTEIN IN METYLOTROPHIC Yeast Varieties.
DK643188D0 (en) EXPRESSION OF HIV PROTEINS IN E.COLI AND S.CEREVISIAE
DE68913304T2 (en) TRANSESTERIFICATION OF ALKOXYESTERS.
NO891715D0 (en) EXPRESSION OF INTERFERON-8 IN METYLOTROPHIC YEARS.
FI874474A0 (en) ANORDNING FOER DOSERING AV GAS IN I EN VAETSKA.
ATE59407T1 (en) EXPRESSION OF EPA IN MAMMALIAN CELLS.
NO891717D0 (en) EXPRESSION OF HIV 24 KDA GAG PROTEIN IN METYLOTROPHIC Yeast Varieties.
FI870848A0 (en) ANORDNING FOER DRAGNING AV KABLAR IN I SKYDDSROER FOER KABLAR.
SE8700550D0 (en) ELD CLASS IN BIOMASS
DK661687A (en) SELECTIVE APPLIANCE REGULATING SUBSTANCES OF BIOLOGICAL ORIGIN IN PURIFIED FORM, THEIR ANTIBODIES AND MEDICINES CREATED IMMUNIC COMPLEXES AND THE PREPARATION OF SUBSTANCES, ANTIBODIES AND COMPLEXS
ATE94207T1 (en) EXPRESSION OF HIGHER EUKARYOTIC GENES IN ASPERGILLUS.

Legal Events

Date Code Title Description
MK1K Patent expired